PNTG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Pennant Group Inc. (PNTG) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock demonstrates strong long-term growth potential, positive analyst sentiment, and a bullish technical setup, making it an attractive entry point despite some minor short-term risks.
The stock is in a bullish trend with SMA_5 > SMA_20 > SMA_200, indicating upward momentum. The MACD is positive at 0.268, suggesting bullish momentum, while RSI at 67.984 is neutral, not yet overbought. The stock is trading near its resistance level (R1: 31.76), but the overall trend supports further upside.
Analysts have consistently raised price targets, with the latest targets ranging between $34 and $40, reflecting optimism about the company's growth potential.
The company operates in a growing healthcare sector with favorable reimbursement trends and strong M&A momentum.
Revenue growth of 26.76% YoY in Q3 2025 highlights robust top-line expansion.
Net income and EPS declined YoY in Q3 2025, reflecting some profitability challenges.
Gross margin slightly contracted, which may indicate rising operational costs.
Short-term stock trend analysis suggests potential for minor pullbacks (-0.76% in the next week, -6.89% in the next month).
In Q3 2025, revenue increased by 26.76% YoY to $229.04M, showcasing strong growth. However, net income dropped by 2.00% YoY to $6.08M, and EPS declined by 15.00% YoY to 0.17, indicating some profitability pressures. Gross margin slightly decreased to 12.72%.
Analyst sentiment is highly positive, with multiple upgrades and raised price targets. Recent ratings include a $38 target from Wells Fargo, $40 from Jefferies, and $34 from Truist, all maintaining Buy or Overweight ratings. Analysts highlight the company's durable growth outlook, favorable reimbursement trends, and attractive valuation.
